Vaccines and COVID-19
Last Update: Apr 17, 2024
This page lists emerging information and publications in COVID-19 Genomics and Precision Health portal that are relevant to vaccine development, evaluation, implementation and impact. For additional information on vaccines and COVID-19. Check out general CDC Information pages.
Recent Publications
-
Pityriasis following COVID-19 vaccinations: a systematic review.
Duzett Laura, et al. Dermatology reports 2024 0 0. (1) 9742
-
Effect of Paxlovid in COVID-19 treatment during the periods of SARS-CoV-2 Omicron BA.5 and BN.1 subvariant dominance in the Republic of Korea: a retrospective cohort study.
Kim Dong-Hwi, et al. Osong public health and research perspectives 2024 0 0.
-
Poor durability of the neutralizing response against XBB sublineages after a bivalent mRNA COVID-19 booster dose in persons with HIV.
Matusali Giulia, et al. Journal of medical virology 2024 0 0. (4) e29598
-
Duration of antibody response to the receptor binding domain of SARS-CoV-2 in infected or vaccinated individuals - A one year retrospective cohort study.
Pasev Martin, et al. International immunopharmacology 2024 0 0. 112084
-
Perinatal outcomes after admission with COVID-19 in pregnancy: a UK national cohort study.
Engjom Hilde Marie, et al. Nature communications 2024 0 0. (1) 3234
-
COVID-19 drug discovery and treatment options.
Chan Jasper Fuk-Woo, et al. Nature reviews. Microbiology 2024 0 0.
-
Genes involved in the limited spread of SARS-CoV-2 in the lower respiratory airways of hamsters may be associated with adaptive evolution.
Takada Kosuke, et al. Journal of virology 2024 0 0. e0178423
-
Epitopes of an antibody that neutralizes a wide range of SARS-CoV-2 variants in a conserved subdomain 1 of the spike protein.
Ishimaru Hanako, et al. Journal of virology 2024 0 0. e0041624
-
Immune response kinetics to SARS-CoV-2 infection and COVID-19 vaccination among nursing home residents-Georgia, October 2020-July 2022.
Chisty Zeshan A, et al. PloS one 2024 0 0. (4) e0301367
-
Assessing the impact of Australia's mass vaccination campaigns over the Delta and Omicron outbreaks.
Lin Lixin, et al. PloS one 2024 0 0. (4) e0299844
-
Higher correlation between neutralizing antibodies and surrogate neutralizing or binding antibodies in COVID-19 patients than vaccine recipients.
Lerdsamran Hatairat, et al. PloS one 2024 0 0. (4) e0298033
-
JN.1 variant in enduring COVID-19 pandemic: is it a variety of interest (VoI) or variety of concern (VoC)?
Kamble Prafull, et al. Hormone molecular biology and clinical investigation 2024 0 0.
-
Traditional Chinese medicine for the COVID-19 pandemic: An online cross-sectional survey among health care workers.
Jin Xinyan, et al. European journal of integrative medicine 2024 0 0. 102273
-
A Stochastic Mobility-Driven Spatially Explicit SEIQRD covid-19 Model with VOCs, Seasonality, and Vaccines.
Alleman Tijs W, et al. Applied mathematical modelling 2024 0 0.
-
A review on Gaucher disease: therapeutic potential of β-glucocerebrosidase-targeted mRNA/saRNA approach.
Feng Shunping, et al. International journal of biological sciences 2024 0 0. (6) 2111-2129
-
Intravenous immunoglobulin therapy for COVID-19 in immunocompromised patients: a retrospective cohort study.
Gröning Remigius, et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2024 0 0. 107046
-
Unlocking the potential of nanocarrier-mediated mRNA delivery across diverse biomedical frontiers: A comprehensive review.
Pawar Smita, et al. International journal of biological macromolecules 2024 0 0. 131139
-
Comparative safety profile of bivalent and original COVID-19 mRNA vaccines regarding myocarditis/pericarditis: A pharmacovigilance study.
Chen Congqin, et al. International immunopharmacology 2024 0 0. 112022
-
Lower prevalence of post-Covid-19 Condition following Omicron SARS-CoV-2 infection.
de Bruijn Siméon, et al. Heliyon 2024 0 0. (7) e28941
-
Correction to: Discordant Antibody and T-Cell Responses to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in Coronavirus Disease 2019 Messenger RNA Vaccine Recipients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2024 0 0. .Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2024 0 0.
Get All Vacccine Records
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 17, 2024
- Content source: